Trial Profile
The pharmacokinetics, pharmacodynamics and tolerability of single-dose rivaroxaban after multiple dosing with omeprazole.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Sep 2011
Price :
$35
*
At a glance
- Drugs Omeprazole (Primary) ; Rivaroxaban (Primary)
- Indications Gastro-oesophageal reflux; Peptic ulcer; Thromboembolism
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 01 Sep 2011 Geometric mean ratios for AUC last, AUC infinity, and Cmax within specified range (primary endpoints met ) as reported in Journal of Cardiovascular Pharmacology
- 01 Sep 2011 New trial record